Status:
COMPLETED
Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples
Lead Sponsor:
Heidelberg University
Conditions:
Invasive Aspergillosis
Eligibility:
All Genders
5-80 years
Brief Summary
Diagnosing invasive pulmonary aspergillosis (IPA) remains a challenge in patients (pts) with hematological malignancies. The clinical significance of testing bronchoalveolar lavage (BAL) samples both ...
Eligibility Criteria
Inclusion
- \- hematological patients with lung infiltrates at high risk for invasive aspergillosis
Exclusion
- \- patients without informed consent
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT01430663
Start Date
April 1 2007
End Date
February 1 2011
Last Update
April 20 2020
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Innsbruck University Hospital
Innsbruck, Austria
2
Cologne University Hospital
Cologne, Germany
3
Erlangen University Hospital
Erlangen, Germany
4
General Hospital Frankfurt (Oder)
Frankfurt (Oder), Germany